Capital Research Global Investors Pfizer Inc Transaction History
Capital Research Global Investors
- $466 Billion
- Q4 2024
A detailed history of Capital Research Global Investors transactions in Pfizer Inc stock. As of the latest transaction made, Capital Research Global Investors holds 1,510,462 shares of PFE stock, worth $38.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,510,462
Previous 1,507,603
0.19%
Holding current value
$38.6 Million
Previous $43.6 Million
8.15%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding PFE
# of Institutions
3,329Shares Held
3.68BCall Options Held
101MPut Options Held
131M-
Vanguard Group Inc Valley Forge, PA519MShares$13.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.8 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.42 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$3.97 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.57 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $143B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...